Finansal

Tartışmalar Teknikler Tahmin Mevsimlik

Toplam Mesuliyetler'in Tarsus Pharmaceuticals, Inc.

Yıllık veri

2019

2020

2021

2022

2023

2024

‪0,00‬

‪‪40,00 M‬‬

‪‪80,00 M‬‬

‪‪120,00 M‬‬

‪‪160,00 M‬‬

Dönem

Değer

Değişim

Değişim %

2024

‪‪152,81 M‬‬

+‪‪83,58 M‬‬

+‪120,71‬%

2023

‪‪69,24 M‬‬

+‪‪34,27 M‬‬

+‪98,03‬%

2022

‪‪34,96 M‬‬

+‪‪22,79 M‬‬

+‪187,12‬%

2021

‪‪12,18 M‬‬

+‪‪6,18 M‬‬

+‪103,22‬%

2020

‪‪5,99 M‬‬

+‪‪5,07 M‬‬

+‪552,01‬%

2019

3 ay veri

Q1 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0,00‬

‪‪40,00 M‬‬

‪‪80,00 M‬‬

‪‪120,00 M‬‬

‪‪160,00 M‬‬

Dönem

Değer

Değişim

Değişim %

Q4 '24

‪‪152,81 M‬‬

+‪‪13,99 M‬‬

+‪10,08‬%

Q3 '24

‪‪138,82 M‬‬

+‪‪14,22 M‬‬

+‪11,41‬%

Q2 '24

‪‪124,60 M‬‬

+‪‪50,53 M‬‬

+‪68,22‬%

Q1 '24

‪‪74,07 M‬‬

+‪‪4,83 M‬‬

+‪6,98‬%

Q4 '23

‪‪69,24 M‬‬

+‪‪14,57 M‬‬

+‪26,65‬%

Q3 '23

‪‪54,67 M‬‬

+‪‪13,47 M‬‬

+‪32,70‬%

Q2 '23

‪‪41,20 M‬‬

+‪‪3,39 M‬‬

+‪8,96‬%

Q1 '23

‪‪37,81 M‬‬

+‪‪2,85 M‬‬

+‪8,14‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q1 '20